Your browser doesn't support javascript.
loading
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
Kim, Shana J; Huzarski, Tomasz; Gronwald, Jacek; Singer, Christian F; Møller, Pål; Lynch, Henry T; Armel, Susan; Karlan, Beth Y; Foulkes, William D; Neuhausen, Susan L; Senter, Leigha; Eisen, Andrea; Eng, Charis; Panchal, Seema; Pal, Tuya; Olopade, Olufunmilayo; Zakalik, Dana; Lubinski, Jan; Narod, Steven A; Kotsopoulos, Joanne.
Afiliação
  • Kim SJ; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
  • Huzarski T; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Gronwald J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Møller P; Inherited Cancer Research Group, Department for Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Lynch HT; Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Armel S; Surgical Center for Hereditary Tumors, HELIOS University Clinic Wuppertal, University Witten-Herdecke, Wuppertal, Germany.
  • Karlan BY; Hereditary Cancer Center, Creighton University School of Medicine, Omaha, NE, USA.
  • Foulkes WD; Department of Gynecologic Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Neuhausen SL; Women's Cancer Program, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Senter L; Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, Quebec, Canada.
  • Eisen A; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Eng C; Division of Human Genetics, Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
  • Panchal S; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Pal T; Genomic Medicine Institute, Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, OH, USA.
  • Olopade O; Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Zakalik D; Vanderbilt-Ingram Cancer Center/Vanderbilt University Medical Center, Nashville, TN, USA.
  • Lubinski J; Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Narod SA; Cancer Genetics Program, Beaumont Hospital, Royal Oak, MI, USA.
  • Kotsopoulos J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Int J Epidemiol ; 47(3): 987-997, 2018 Jun 01.
Article em En | MEDLINE | ID: mdl-29547931
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Epidemiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Epidemiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá